News
Seminar Briefing: The UK Biotech Sector and Brexit
1 May 2018
In this paper, Sir Geoffrey Owen and Dr Michael Hopkins discuss ‘The UK Biotech Sector and Brexit: Past Performance and Future Prospects’.
Professor Graham Cookson Appointed OHE Director Designate
24 April 2018
The Office of Health Economics Trustees have appointed Professor Graham Cookson as Director Designate. He will be the successor to Professor Adrian Towse as OHE Director.…
New Publications: Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions
18 April 2018
Just published are two new reports that explore the use of real world evidence for coverage and formulary decisions. The publications represent 1) the background paper…
New Methods for Analysing the Distribution of EQ-5D Observations
17 April 2018
Our latest OHE Research Paper presents new methods for summarising EQ-5D data from patients.
Valuing Health at the End of Life: A Review of Stated Preference Studies in the Social Sciences Literature
9 April 2018
Just published in Social Science & Medicine: a review of stated preferences examining the extent of support for an end of life premium.
Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?
4 April 2018
A recently published editorial by OHE’s David Mott considers whether quantitative patient preference data has a role to play in HTA decision making.
Value Frameworks: Value in Health Special Issue
29 March 2018
A recent issue of Value in Health contains the ISPOR Special Task Force Report on US Value Assessment Frameworks. In this blog post, we summarise the…
Appraising Ultra-Orphan Drugs: Is Cost-per-QALY Appropriate?
22 March 2018
A new OHE report discusses NICE’s introduction of a cost-effectiveness threshold to appraise ultra-orphan drugs.
Minimal Access Surgery – Why Don’t We Do More?
20 March 2018
OHE Consulting publishes a report on the barriers to the uptake of minimal access surgery in the NHS and private sector.